TXNDC5 and nonpapillary renal cell carcinoma: Knockout of TXNDC5 can make clear cell renal cell carcinoma (ccRCC) cells allergic to chemotherapy drugs (such as camptothecin and 5-fluorouracil) and inhibit the growth, migration, and invasion of ccRCC cells [42].